HomeNewsBusinessCNBC-TV18 CommentsMankind Pharma eyes top slot in industry by 2016
Trending Topics
Sensex Live
Meesho IPO
Sudeep Pharma Share Price
Aequs IPO
Gold Price

Mankind Pharma eyes top slot in industry by 2016

Chairman of Mankind Pharma, Ramesh Juneja, tells CNBC-TV18 that they aim to enter the league of top five in the pharma space in the next three years and reach the top slot by 2016.

January 16, 2012 / 20:10 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

At the sidelines of the IDMA event, chairman of Mankind Pharma, Ramesh Juneja, told CNBC-TV18

TAGS: #CNBC-TV18 Comments #drug pricing policy #Mankind Pharma #pharma space
first published: Jan 13, 2012 06:23 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.